Bai W, Xu J, Gu W, Wang D, Cui Y, Rong W
Nat Commun. 2025; 16(1):474.
PMID: 39774694
PMC: 11707192.
DOI: 10.1038/s41467-024-55481-7.
Dai W, Qiao X, Fang Y, Guo R, Bai P, Liu S
Signal Transduct Target Ther. 2024; 9(1):332.
PMID: 39592582
PMC: 11627502.
DOI: 10.1038/s41392-024-02039-0.
Conway K, Edmiston S, Vondras A, Reiner A, Corcoran D, Shen R
JCO Precis Oncol. 2024; 8:e2400375.
PMID: 39509669
PMC: 11737429.
DOI: 10.1200/PO-24-00375.
Zhou R, Tang X, Wang Y
Nat Rev Cancer. 2024; 24(12):850-866.
PMID: 39433978
DOI: 10.1038/s41568-024-00754-y.
Esposito A, Ferraresi A, Vallino L, Garavaglia B, Dhanasekaran D, Isidoro C
Int J Biol Sci. 2024; 20(13):5293-5311.
PMID: 39430243
PMC: 11488579.
DOI: 10.7150/ijbs.96469.
Epigenomic heterogeneity as a source of tumour evolution.
Laisne M, Lupien M, Vallot C
Nat Rev Cancer. 2024; 25(1):7-26.
PMID: 39414948
DOI: 10.1038/s41568-024-00757-9.
BRAF mutations and the association of V600E with CD133 and CDX2 expression in a Pakistani colorectal carcinoma cohort.
Hassan S, Mirza T, Khatoon A, Bukhari U, Shaikh F, Karim A
BMC Cancer. 2024; 24(1):1162.
PMID: 39300378
PMC: 11411998.
DOI: 10.1186/s12885-024-12925-z.
A cellular identity crisis? Plasticity changes during aging and rejuvenation.
Gorelov R, Hochedlinger K
Genes Dev. 2024; 38(17-20):823-842.
PMID: 39293862
PMC: 11535162.
DOI: 10.1101/gad.351728.124.
Epigenome Reprogramming Through H3K27 and H3K4 Trimethylation as a Resistance Mechanism to DNA Methylation Inhibition in BRAFV600E-Mutated Colorectal Cancer.
Lee H, Saw A, Morris V, Napolitano S, Bristow C, Srinivasan S
Clin Cancer Res. 2024; 30(22):5166-5179.
PMID: 39269307
PMC: 11829253.
DOI: 10.1158/1078-0432.CCR-24-1166.
Cancer-associated DNA hypermethylation of Polycomb targets requires DNMT3A dual recognition of histone H2AK119 ubiquitination and the nucleosome acidic patch.
Gretarsson K, Abini-Agbomson S, Gloor S, Weinberg D, McCuiston J, Kumary V
Sci Adv. 2024; 10(35):eadp0975.
PMID: 39196936
PMC: 11352909.
DOI: 10.1126/sciadv.adp0975.
Dissecting the impact of differentiation stage, replicative history, and cell type composition on epigenetic clocks.
Gorelov R, Weiner A, Huebner A, Yagi M, Haghani A, Brooke R
Stem Cell Reports. 2024; 19(9):1242-1254.
PMID: 39178844
PMC: 11411293.
DOI: 10.1016/j.stemcr.2024.07.009.
Exploring Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-Associated Protein 9 (CRISPR-Cas9) as a Therapeutic Modality for Cancer: A Scoping Review.
Balasubramanian A, Veluswami K, Rao S, Aggarwal S, Mani S
Cureus. 2024; 16(7):e64324.
PMID: 39130943
PMC: 11316854.
DOI: 10.7759/cureus.64324.
A comprehensive overview of the molecular features and therapeutic targets in BRAF-mutant colorectal cancer.
Gu R, Fang H, Wang R, Dai W, Cai G
Clin Transl Med. 2024; 14(7):e1764.
PMID: 39073010
PMC: 11283586.
DOI: 10.1002/ctm2.1764.
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets.
Zhang S, Xiao X, Yi Y, Wang X, Zhu L, Shen Y
Signal Transduct Target Ther. 2024; 9(1):149.
PMID: 38890350
PMC: 11189549.
DOI: 10.1038/s41392-024-01848-7.
Statistical Models for High-Risk Intestinal Metaplasia with DNA Methylation Profiling.
Wang T, Huang Y, Yang J
Epigenomes. 2024; 8(2).
PMID: 38804368
PMC: 11130831.
DOI: 10.3390/epigenomes8020019.
Modelling esophageal adenocarcinoma and Barrett's esophagus with patient-derived organoids.
Milne J, Mustafa E, Clemons N
Front Mol Biosci. 2024; 11:1382070.
PMID: 38721276
PMC: 11076827.
DOI: 10.3389/fmolb.2024.1382070.
Nonlinear DNA methylation trajectories in aging male mice.
Olecka M, van Bommel A, Best L, Haase M, Foerste S, Riege K
Nat Commun. 2024; 15(1):3074.
PMID: 38594255
PMC: 11004021.
DOI: 10.1038/s41467-024-47316-2.
Altered lipid metabolism in APC-driven colorectal cancer: the potential for therapeutic intervention.
Kelson C, Zaytseva Y
Front Oncol. 2024; 14:1343061.
PMID: 38590663
PMC: 10999677.
DOI: 10.3389/fonc.2024.1343061.
Intestinal carcinogenicity screening of environmental pollutants using organoid-based cell transformation assay.
Wang Z, Chen S, Guo Y, Zhang R, Zhang Q, Jiang X
Arch Toxicol. 2024; 98(6):1937-1951.
PMID: 38563870
DOI: 10.1007/s00204-024-03729-y.
Hypermethylated Colorectal Cancer Tumours Present a Myc-Driven Hypermetabolism with a One-Carbon Signature Associated with Worsen Prognosis.
Desterke C, Jaulin F, Dornier E
Biomedicines. 2024; 12(3).
PMID: 38540202
PMC: 10968523.
DOI: 10.3390/biomedicines12030590.